Alto Neuroscience Inc. (ANRO)
NYSE: ANRO
· Real-Time Price · USD
3.15
0.03 (0.96%)
At close: Aug 15, 2025, 3:59 PM
3.14
-0.32%
After-hours: Aug 15, 2025, 05:05 PM EDT
Alto Neuroscience Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 |
Revenue | 394K | 394K | 394K | 372K | 372K | 372K | 372K | n/a | n/a | n/a | n/a |
Cost of Revenue | 371K | 471K | 397K | 489K | 384K | 384K | 373K | 378K | 283K | 183K | 97K |
Gross Profit | -174K | -274K | -200K | -117K | -384K | -384K | -373K | -750K | -283K | -183K | -97K |
Operating Income | -70.24M | -69.9M | -68.61M | -63.38M | -54.21M | -44.99M | -37.81M | -34.1M | -24.39M | -15.26M | -8.06M |
Interest Income | 8.14M | 9.12M | 8.85M | 7.45M | 5.67M | 3.68M | 2.35M | 1.72M | 1.01M | 342K | 112K |
Pretax Income | -64.86M | -63.18M | -61.43M | -57.45M | -49.8M | -42.44M | -36.3M | -32.74M | -23.6M | -14.94M | -7.65M |
Net Income | -64.86M | -63.18M | -61.43M | -57.45M | -49.8M | -42.44M | -36.3M | -32.74M | -23.6M | -14.94M | -7.65M |
Selling & General & Admin | 23.28M | 22.88M | 21.52M | 17.35M | 13.28M | 10.07M | 7.24M | 6.85M | 5.1M | 3.15M | 1.64M |
Research & Development | 46.96M | 47.02M | 47M | 45.84M | 40.75M | 34.63M | 30.29M | 26.97M | 19M | 11.93M | 6.32M |
Other Expenses | n/a | n/a | n/a | 92K | 92K | 92K | 92K | n/a | n/a | n/a | n/a |
Operating Expenses | 70.24M | 69.9M | 68.51M | 63.28M | 54.11M | 44.8M | 37.62M | 33.82M | 24.1M | 15.08M | 7.96M |
Interest Expense | 634K | 1.63M | 1.38M | 1.4M | 1.41M | 1.39M | 1.37M | 1.01M | 651K | 324K | n/a |
Selling & Marketing Expenses | n/a | n/a | -97K | -189K | -189K | -289K | -278K | -283K | -283K | -183K | -97K |
Cost & Expenses | 51.56M | 69.9M | 68.61M | 63.38M | 54.21M | 44.99M | 37.81M | 34.1M | 24.39M | 15.26M | 8.06M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 27.07M | 27.05M | 26.99M | 26.96M | 26.95M | 26.88M | 26.88M | 26.88M | 26.88M | 26.88M | 25.57M |
Shares Outstanding (Diluted) | 27.07M | 27.05M | 26.99M | 26.96M | 26.95M | 26.88M | 26.88M | 26.88M | 26.88M | 26.88M | 25.57M |
EPS (Basic) | -2.39 | -2.33 | -2.27 | -2.13 | -1.85 | -1.58 | -1.35 | -1.23 | -0.89 | -0.57 | -0.3 |
EPS (Diluted) | -2.39 | -2.33 | -2.27 | -2.13 | -1.85 | -1.58 | -1.35 | -1.23 | -0.89 | -0.57 | -0.3 |
EBITDA | -65.37M | -62.27M | -59.57M | -55.64M | -48.02M | -40.67M | -34.57M | -31.36M | -22.66M | -14.43M | -7.55M |
EBIT | -45.87M | -61.56M | -60.06M | -56.05M | -48.39M | -41.05M | -34.94M | -31.73M | -22.95M | -14.61M | -7.65M |
Depreciation & Amortization | 463K | 576K | 502K | 424K | 385K | 372K | 361K | 366K | 283K | 183K | 97K |